ImmunityBio, Inc. (IBRX) intrinsic value

Price $10.29 on 2026-10-05.

MethodValueMargin of safety
DCF – bear case-$51.71
DCF – base case-$118.51-1252.3%
DCF – bull case-$232.92
Graham Number——

WACC 5.2%, revenue growth 93.9%, FCF margin -112.5%, EPS -$0.96, book value per share -$0.99. 2 valuation runs recorded.

Community analyses of IBRX

More valuations

Run your own DCF · How accurate are these valuations?